Observational studyNeurosciences (Riyadh, Saudi Arabia)2022

Efficacy and safety of rituximab in patients with multiple sclerosis: An observational study at a tertiary center in Makkah, Saudi Arabia.

Yassir M Almatrafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.